Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Gregory Friedman, MD) · gkfriedman@mdanderson.org · 713-835-4467
Contact: Principal Investigator (Gregory Friedman, MD)

Study leads

Gregory Kane Friedman Friedman, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Glioblastoma Multiforme of Brain · Glioma · Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Chicago, United States

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Childhood Astrocytoma · Childhood Diffuse Intrinsic Pontine Glioma · Childhood Diffuse Midline Glioma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Los Angeles, United States

A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

CNS Malignancies · Medulloblastoma Recurrent · ATRT Recurrent

Abroad (travel likely)RecruitingEARLY_PHASE1

Washington D.C., United States

18F-Fluciclovine PET-MRI in High-grade Glioma

Glioma · High Grade Glioma · Glioma, Malignant

Abroad (travel likely)RecruitingEARLY_PHASE1

Philadelphia, United States